Related Experiment Videos
Lower gastrointestinal bleeding during anticoagulant therapy: a life-saving complication?
1Department of Surgery, Frenchay Hospital, Bristol.
Annals of the Royal College of Surgeons of England
|January 1, 1997
Summary
Lower gastrointestinal bleeding in patients taking warfarin may indicate underlying colon cancer. Early diagnosis through bleeding events can lead to better patient prognoses.
Area of Science:
- Gastroenterology
- Oncology
- Hematology
Background:
- Warfarin is a widely prescribed anticoagulant for thromboembolic disease.
- Hemorrhage is a known, potentially life-threatening complication of warfarin therapy.
Purpose of the Study:
- To investigate the association between lower gastrointestinal bleeding during warfarin therapy and the detection of large bowel malignancy.
- To highlight the importance of thorough investigation of bleeding events in patients on anticoagulation.
Main Methods:
- Retrospective case series of eight patients experiencing lower gastrointestinal bleeding while on warfarin.
- Analysis of diagnostic findings, focusing on the identification of colorectal cancer.
Main Results:
- Eight cases identified where lower gastrointestinal bleeding led to the diagnosis of previously unrecognized large bowel malignancy.
- In 30-50% of anticoagulant-related bleeding cases, an underlying organic lesion is present, even with prolonged prothrombin times.
Conclusions:
- Lower gastrointestinal bleeding in patients on warfarin can be an early indicator of asymptomatic colorectal cancer.
- Prompt investigation of such bleeding, particularly in the elderly, may facilitate earlier cancer diagnosis and potentially improve patient outcomes.